Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin L Winthrop

Showing results (1-10 of 317) with videos related to

Pageof 32
Sort By:
Future Microbiology|March 10, 2010
Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's viewKevin L Winthrop
Nature Clinical Practice. Rheumatology|November 1, 2006
Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factorKevin L Winthrop
Nature Reviews. Rheumatology|March 3, 2017
The emerging safety profile of JAK inhibitors in rheumatic diseaseKevin L Winthrop
Nature Reviews. Rheumatology|April 1, 2017
The emerging safety profile of JAK inhibitors in rheumatic diseaseKevin L Winthrop
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2020
Who Needs a Corona?Kevin L Winthrop
Rheumatic Diseases Clinics of North America|November 10, 2012
Infections and biologic therapy in rheumatoid arthritis: our changing understanding of risk and preventionKevin L Winthrop
Nature Reviews. Rheumatology|July 2, 2009
Preventing and treating biologic-associated opportunistic infectionsKevin L Winthrop, Tom Chiller
Infectious Disease Clinics of North America|May 24, 2020
Mycobacterial Infections Potentiated by BiologicsCassandra Calabrese, Kevin L Winthrop
Annals of the Rheumatic Diseases|March 4, 2021
Rheumatology and COVID-19 at 1 year: facing the unknownsLeonard Calabrese, Kevin L Winthrop
Nature Reviews. Rheumatology|June 2, 2017
Pharmacotherapy: Biosimilar switching - "To set a form upon desired change"Jonathan Kay, Kevin L Winthrop
Pageof 32

Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Future Microbiology|March 10, 2010
Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's viewKevin L Winthrop
Nature Clinical Practice. Rheumatology|November 1, 2006
Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factorKevin L Winthrop
Nature Reviews. Rheumatology|March 3, 2017
The emerging safety profile of JAK inhibitors in rheumatic diseaseKevin L Winthrop
Nature Reviews. Rheumatology|April 1, 2017
The emerging safety profile of JAK inhibitors in rheumatic diseaseKevin L Winthrop
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2020
Who Needs a Corona?Kevin L Winthrop
Rheumatic Diseases Clinics of North America|November 10, 2012
Infections and biologic therapy in rheumatoid arthritis: our changing understanding of risk and preventionKevin L Winthrop
Nature Reviews. Rheumatology|July 2, 2009
Preventing and treating biologic-associated opportunistic infectionsKevin L Winthrop, Tom Chiller
Infectious Disease Clinics of North America|May 24, 2020
Mycobacterial Infections Potentiated by BiologicsCassandra Calabrese, Kevin L Winthrop
Annals of the Rheumatic Diseases|March 4, 2021
Rheumatology and COVID-19 at 1 year: facing the unknownsLeonard Calabrese, Kevin L Winthrop
Nature Reviews. Rheumatology|June 2, 2017
Pharmacotherapy: Biosimilar switching - "To set a form upon desired change"Jonathan Kay, Kevin L Winthrop
Pageof 32